Factors affecting the frequency of occurrence of spironolactone bodies in aldosteronomas and non-tumorous cortex
- 1 January 1983
- Vol. 15 (3) , 273-277
- https://doi.org/10.3109/00313028309083505
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Aldosterone Producing Adenoma: Fludrocortisone Suppression and Left Adrenal Vein Catheterisation in Definitive Diagnosis and ManagementAustralian and New Zealand Journal of Medicine, 1979
- Spironolactone-induced inhibition of aldosterone biosynthesis in primary aldosteronism: Morphological and functional studiesMetabolism, 1977
- Spironolactone Inclusions in an AldosteronomaAmerican Journal of Clinical Pathology, 1974
- Fine structure and morphogenesis of spironolactone bodies in the zona glomerulosa of the human adrenal cortexJournal of Clinical Pathology, 1973
- Cycloheximide-induced ultrastructural changes in the corpus luteum of ratsCellular and Molecular Life Sciences, 1973
- Pathology of primary aldosteronismCancer, 1966
- CYTOPLASMIC BODIES IN THE ADRENAL CORTEX OF PATIENTS TREATED WITH SPIROLACTONEThe Lancet, 1963